-
Healthcare is Hot for Hedge Funds
In part two of our series, we look at volatility and dispersion among healthcare subsectors.
-
Pivotal Point of View – July 2019
Managed Futures topped both performance and alpha rankings for the month, while Equity Sector strategies remained at the top for 2019.
-
Is Healthcare Just What the Doctor Ordered?
In part one of our two part series, we look at healthcare over time as well as side by side compared to other industries.
-
Does Jerome Powell Control the Fate of Hedge Funds?
CEO Jon Caplis examines the often-overlooked but meaningful relationship between interest rates, overall industry performance, and alpha generation.
-
Pivotal Point of View – June 2019
Hedge funds came back swinging in June, though not all gains were shared equally.
-
New Reporting Standards Being Considered For Hedge Fund Industry
CFA’s new hedge fund performance guidelines try to stop cherry-picking.
-
Risk Factors Feeding Hedge Fund Performance
2019 is showing a big spike in risk factor correlations. Jon Caplis breaks down the data in conversation with Forbes.
-
Pivotal Point of View – May 2019
Welcome to The Pivotal Point of View! Starting this month, we are going to provide a monthly snapshot of how the core strategies we track are performing.
-
Want to Make Money in the Markets? Try Buying some Weed
Significant outperformance relative to peers, especially in difficult years, can have lasting influence on future fund evaluation and investment decisions. Accordingly, some of these same managers are still catching investors’ attention today. What might be the secret? Cannabis.
-
How Important is “Alpha Generation” Really to Hedge Fund Investors?
In early 2019, J.P. Morgan surveyed hedge fund investors to identify their reasons for investing in this space – 88% of respondents cited “alpha generation” as one of the top three motivations. If this is the case for such a high number of investors, it’s important to look at the strategies being pursued in the quest for alpha to see what’s working and what isn’t. We crunched the numbers and found that it’s a good time for a gut check.
Interested in actionable hedge fund data and industry–leading research?
We provide transparency for Allocators.
PivotalPath 2025. All rights reserved.